{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:22:04Z","timestamp":1789842124928,"version":"4.0.1"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56-139561"],"award-info":[{"award-number":["R56-139561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.abb.2020.108679","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T11:55:24Z","timestamp":1606391724000},"page":"108679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD"],"prefix":"10.1016","volume":"697","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-3083","authenticated-orcid":false,"given":"Ariel","family":"Sasson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kristoferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1756283X11430859","article-title":"Secondary causes of nonalcoholic fatty liver disease","volume":"5","author":"Kneeman","year":"2012","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.abb.2020.108679_bib4","first-page":"S186","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"Angulo","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2020.108679_bib6","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.21037\/hbsn.2018.01.01","article-title":"Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario","volume":"7","author":"Vigano","year":"2018","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2468-1253(16)30018-8","article-title":"Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"1","author":"Degasperi","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins","volume":"23","author":"Gonzalez-Periz","year":"2009","journal-title":"Faseb. J."},{"key":"10.1016\/j.abb.2020.108679_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids","volume":"58","author":"Spahis","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2015.04.009","article-title":"Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men","volume":"240","author":"Ozturk","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"Lopez-Velazquez","year":"2014","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.abb.2020.108679_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","article-title":"Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action","volume":"64","author":"Scorletti","year":"2018","journal-title":"Mol. Aspect. Med."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cgh.2017.05.029","article-title":"Long-term outcomes of nonalcoholic fatty liver disease: from nonalcoholic steatohepatitis to nonalcoholic steatofibrosis","volume":"15","author":"Younossi","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"22","key":"10.1016\/j.abb.2020.108679_bib18","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/00365521.2011.634024","article-title":"Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression","volume":"47","author":"Ekstedt","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.abb.2020.108679_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"31","key":"10.1016\/j.abb.2020.108679_bib22","doi-asserted-by":"crossref","first-page":"e4447","DOI":"10.1097\/MD.0000000000004447","article-title":"Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study","volume":"95","author":"Yadav","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","article-title":"Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study","volume":"19","author":"Kim","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib24","first-page":"605","article-title":"Fibroscan (transient elastography) for the measurement of liver fibrosis","volume":"8","author":"Afdhal","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.abb.2020.108679_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2018.05.002","article-title":"A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease","volume":"58","author":"Panera","year":"2018","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1627456","article-title":"Nonalcoholic fatty liver disease in children","volume":"38","author":"Mann","year":"2018","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000001624","article-title":"Systematic review: nutrition and physical activity in the management of paediatric nonalcoholic fatty liver disease","volume":"65","author":"Gibson","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clnu.2016.12.009","article-title":"Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Chen","year":"2018","journal-title":"Clin. Nutr."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib30","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib32","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","article-title":"Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease","volume":"118","author":"Fuster","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-016-0321-5","article-title":"Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease","volume":"15","author":"Paglialunga","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib36","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib37","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/ATVBAHA.115.306740","article-title":"Angiotensinogen exerts effects independent of angiotensin II","volume":"36","author":"Lu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib39","doi-asserted-by":"crossref","first-page":"E1280","DOI":"10.1152\/ajpendo.00277.2006","article-title":"Angiotensin II increases adipose angiotensinogen expression","volume":"292","author":"Lu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.abb.2020.108679_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2016.04.004","article-title":"Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females","volume":"123","author":"Peterson","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/oby.22354","article-title":"Oxidized HDL, adipokines, and endothelial dysfunction: a potential biomarker profile for cardiovascular risk in women with obesity","volume":"27","author":"Peterson","year":"2019","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib42","doi-asserted-by":"crossref","DOI":"10.16966\/2472-6990.109","article-title":"Oxidized HDL and isoprostane exert a potent adipogenic effect on stem cells: where in the lineage?","volume":"2","author":"Peterson","year":"2016","journal-title":"Cell Stem Cells Regen. Med."},{"key":"10.1016\/j.abb.2020.108679_bib43","doi-asserted-by":"crossref","first-page":"3484107","DOI":"10.1155\/2018\/3484107","article-title":"Development of NASH in obese mice is confounded by adipose tissue increase in inflammatory NOV and oxidative stress","volume":"2018","author":"Sacerdoti","year":"2018","journal-title":"Int. J. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8080277","article-title":"Inhibition of heme oxygenase antioxidant activity exacerbates hepatic steatosis and fibrosis in vitro","volume":"8","author":"Raffaele","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9010040","article-title":"Adipocyte specific HO-1 gene therapy is effective in antioxidant treatment of insulin resistance and vascular function in an obese mice model","volume":"9","author":"Singh","year":"2020","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib46","article-title":"Cold-pressed Nigella sativa oil standardized to 3% Thymoquinone potentiates omega-3 protection against obesity-induced oxidative stress, inflammation, and markers of insulin resistance accompanied with conversion of white to beige fat in mice","volume":"9","author":"Shen","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"15","key":"10.1016\/j.abb.2020.108679_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155469","article-title":"Cold press pomegranate seed oil attenuates dietary-obesity induced hepatic steatosis and fibrosis through antioxidant and mitochondrial pathways in obese mice","volume":"21","author":"Raffaele","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1194\/jlr.M300020-JLR200","article-title":"Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER","volume":"44","author":"Liao","year":"2003","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib50","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1194\/jlr.M600203-JLR200","article-title":"Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet","volume":"47","author":"Flowers","year":"2006","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib51","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI30566","article-title":"Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance","volume":"117","author":"Schenk","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1172\/JCI200523962","article-title":"Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1","volume":"115,","author":"Jiang","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.abb.2020.108679_bib53","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"Zambo","year":"2013","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib55","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib58","doi-asserted-by":"crossref","first-page":"G1135","DOI":"10.1152\/ajpgi.2001.281.5.G1135","article-title":"Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress","volume":"281","author":"Robertson","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib61","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/labinvest.2012.45","article-title":"Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis","volume":"92","author":"Dixon","year":"2012","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib63","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1096\/fj.11-189472","article-title":"Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet","volume":"25","author":"Lanthier","year":"2011","journal-title":"Faseb. J."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbrc.2009.05.070","article-title":"Critical role of Kupffer cells in the management of diet-induced diabetes and obesity","volume":"385","author":"Neyrinck","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"29","key":"10.1016\/j.abb.2020.108679_bib66","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Marra","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib69","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/ATVBAHA.109.194050","article-title":"Saturated fatty acids do not directly stimulate Toll-like receptor signaling","volume":"29","author":"Erridge","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib71","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1017\/S0007114511004983","article-title":"Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis","volume":"107","author":"Wagnerberger","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib72","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib73","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2011.05.030","article-title":"High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver","volume":"56","author":"Song","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib75","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.abb.2020.108679_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib77","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib78","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"issue":"47","key":"10.1016\/j.abb.2020.108679_bib80","doi-asserted-by":"crossref","first-page":"36551","DOI":"10.1074\/jbc.M110.168542","article-title":"Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway","volume":"285","author":"Choi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib81","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase","volume":"47","author":"Adachi","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.21995","article-title":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells","volume":"47","author":"Caligiuri","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1016\/j.abb.2020.108679_bib83","first-page":"S102","article-title":"Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation","volume":"21","author":"Tsukamoto","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"Pt 2","key":"10.1016\/j.abb.2020.108679_bib84","first-page":"305","article-title":"Peroxisome proliferator-activated receptor-gamma interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-beta receptor in hepatic stellate cells","volume":"127","author":"Zhang","year":"2014","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.phrs.2012.06.003","article-title":"beta-Catenin pathway is required for TGF-beta1 inhibition of PPARgamma expression in cultured hepatic stellate cells","volume":"66","author":"Qian","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib86","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib87","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.1217611110","article-title":"Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains","volume":"110","author":"Volmer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"29","key":"10.1016\/j.abb.2020.108679_bib88","doi-asserted-by":"crossref","first-page":"22027","DOI":"10.1074\/jbc.M110.126870","article-title":"Decrease in membrane phospholipid unsaturation induces unfolded protein response","volume":"285","author":"Ariyama","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.abb.2020.108679_bib90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-62703-459-3_6","article-title":"Visualization of cGMP with cGi biosensors","volume":"1020","author":"Thunemann","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib91","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20091827","article-title":"Translational control of the sterol-regulatory transcription factor SREBP-1 mRNA in response to serum starvation or ER stress is mediated by an internal ribosome entry site","volume":"429","author":"Damiano","year":"2010","journal-title":"Biochem. J."},{"issue":"39","key":"10.1016\/j.abb.2020.108679_bib92","doi-asserted-by":"crossref","first-page":"29965","DOI":"10.1074\/jbc.M110.128694","article-title":"The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways","volume":"285","author":"Gao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib93","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice","volume":"91","author":"Aharoni-Simon","year":"2011","journal-title":"Lab. Invest."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib94","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.18632\/oncotarget.14371","article-title":"Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice","volume":"8","author":"Sommer","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib95","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1alpha overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2019.04.029","article-title":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1alpha-HO-1-PGC1alpha-mitochondrial signaling","volume":"380","author":"Raffaele","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.abb.2020.108679_bib97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2016.07.004","article-title":"PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: role of epoxyeicosatrienoic acid","volume":"125","author":"Singh","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metabol."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib99","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0968-0004(97)01129-8","article-title":"ATP synthase: an electrochemical transducer with rotatory mechanics","volume":"22","author":"Junge","year":"1997","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/emboj.2008.35","article-title":"Dimer ribbons of ATP synthase shape the inner mitochondrial membrane","volume":"27","author":"Strauss","year":"2008","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib101","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib103","doi-asserted-by":"crossref","first-page":"R311","DOI":"10.1152\/ajpregu.00735.2007","article-title":"Attenuation of acute and chronic liver injury in rats by iron-deficient diet","volume":"294","author":"Otogawa","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib104","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00125-019-05024-3","article-title":"Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality","volume":"63","author":"Brouwers","year":"2020","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12020-012-9712-1","article-title":"Assessment of endothelial function in patients with nonalcoholic fatty liver disease","volume":"43","author":"Colak","year":"2013","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib107","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib108","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib109","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.02.023","article-title":"Fatty liver is an independent predictor of early carotid atherosclerosis","volume":"65","author":"Pais","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib110","first-page":"55","article-title":"Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis","volume":"7","author":"Nahandi","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib111","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/CS20130036","article-title":"Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes","volume":"125","author":"Targher","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib113","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.09090769","article-title":"Presence of coronary plaques in patients with nonalcoholic fatty liver disease","volume":"254","author":"Assy","year":"2010","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib114","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1210\/jc.2016-1525","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification development: a longitudinal study","volume":"101","author":"Park","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","article-title":"Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease","volume":"58","author":"Hallsworth","year":"2013","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib116","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/HJH.0b013e32833a7de6","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study","volume":"28","author":"Salvi","year":"2010","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib117","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/MEG.0000000000001191","article-title":"Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?","volume":"30","author":"Oikonomou","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/children4070057","article-title":"The association between non-alcoholic fatty liver disease and cardiovascular risk in children","volume":"4","author":"Di Sessa","year":"2017","journal-title":"Children"},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib119","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/circj.CJ-08-1169","article-title":"Endothelial dysfunction: the first step toward coronary arteriosclerosis","volume":"73,","author":"Vanhoutte","year":"2009","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.abb.2020.108679_bib122","doi-asserted-by":"crossref","first-page":"174782","DOI":"10.1155\/2013\/174782","article-title":"Assessment of endothelial dysfunction in childhood obesity and clinical use","volume":"2013","author":"Bruyndonckx","year":"2013","journal-title":"Oxid. Med. Cell Longev."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031799","article-title":"Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease","volume":"7","author":"Chiang","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib124","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2265.2012.04460.x","article-title":"Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"78","author":"Dogru","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.metabol.2010.07.027","article-title":"Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"60","author":"Kasumov","year":"2011","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib126","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib127","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.abb.2020.108679_bib128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2891-12-37","article-title":"Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"de Carvalho","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.abb.2020.108679_bib129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-511X-10-60","article-title":"High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway","volume":"10","author":"Bravo","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib130","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2005.03891.x","article-title":"Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease","volume":"20","author":"Gulsen","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib132","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.22037","article-title":"The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats","volume":"47","author":"Distrutti","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib133","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227,","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib134","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib136","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport","volume":"21","author":"von Eckardstein","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl A","key":"10.1016\/j.abb.2020.108679_bib138","first-page":"A24","article-title":"Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches","volume":"19","author":"Chapman","year":"1998","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib139","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.abb.2020.108679_bib140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","article-title":"The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases","volume":"66","author":"Brown","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"1 Suppl","key":"10.1016\/j.abb.2020.108679_bib141","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib142","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib143","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-11-0864","article-title":"Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies","volume":"166","author":"Haukeland","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib144","doi-asserted-by":"crossref","first-page":"e1765","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige","year":"2008","journal-title":"PloS One"},{"issue":"3A","key":"10.1016\/j.abb.2020.108679_bib145","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/S0002-9149(02)03144-2","article-title":"Role of oxidative stress in atherosclerosis","volume":"91","author":"Harrison","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.abb.2020.108679_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.009","article-title":"Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective","volume":"78","author":"Santilli","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib147","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ejim.2014.09.007","article-title":"Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis","volume":"25","author":"Leach","year":"2014","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib148","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/07853890801946515","article-title":"Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro\/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis","volume":"40","author":"Musso","year":"2008","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib149","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/10408363.2014.992063","article-title":"Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases","volume":"52","author":"Trpkovic","year":"2015","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.abb.2020.108679_bib150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"J. Inflamm."},{"issue":"12","key":"10.1016\/j.abb.2020.108679_bib151","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/CIRCULATIONAHA.105.535294","article-title":"Role of angiogenesis in cardiovascular disease: a critical appraisal","volume":"112","author":"Khurana","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib152","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0b013e3182254283","article-title":"Centrizonal arteries and microvessels in nonalcoholic steatohepatitis","volume":"35","author":"Gill","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib153","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cyto.2012.05.001","article-title":"Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease","volume":"59","author":"Coulon","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib154","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arcmed.2010.12.001","article-title":"Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"42","author":"Yilmaz","year":"2011","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib156","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11739-009-0240-9","article-title":"Olivetti Heart Study Research, G., Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy","volume":"4","author":"Barbato","year":"2009","journal-title":"Intern. Emerg. Med."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib157","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib158","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004918","article-title":"Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease","volume":"6","author":"Song","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib159","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","volume":"31","author":"Kotronen","year":"2011","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","author":"Tripodi","year":"2014","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.abb.2020.108679_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162473","article-title":"Epicardial adipose tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease","volume":"11","author":"Fracanzani","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib162","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacl.2016.01.008","article-title":"Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: from the CAESAR study","volume":"10","author":"Kim","year":"2016","journal-title":"J. Clin. Lipidol."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib163","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrendo.2015.58","article-title":"Local and systemic effects of the multifaceted epicardial adipose tissue depot","volume":"11","author":"Iacobellis","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.abb.2020.108679_bib164","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-2008-1062724","article-title":"The double role of epicardial adipose tissue as pro- and anti-inflammatory organ","volume":"40","author":"Iacobellis","year":"2008","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cyto.2012.08.012","article-title":"Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study","volume":"60","author":"Teijeira-Fernandez","year":"2012","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib166","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0030-1250211","article-title":"Adiponectin--its potential to predict and prevent coronary artery disease","volume":"59","author":"Skrabal","year":"2011","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.abb.2020.108679_bib167","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcell.2017.00044","article-title":"More than just a simple cardiac envelope; cellular contributions of the epicardium","volume":"5","author":"Duenas","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib168","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12967-016-0999-1","article-title":"Type 2 diabetes is associated with decreased PGC1alpha expression in epicardial adipose tissue of patients with coronary artery disease","volume":"14","author":"Moreno-Santos","year":"2016","journal-title":"J. Transl. Med."},{"issue":"20","key":"10.1016\/j.abb.2020.108679_bib169","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10517-017-3860-5","article-title":"Adipokine and cytokine profiles of epicardial and subcutaneous adipose tissue in patients with coronary heart disease","volume":"163","author":"Gruzdeva","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib171","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00380-012-0315-9","article-title":"Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes","volume":"29","author":"Bambace","year":"2014","journal-title":"Heart Ves."},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib172","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.ijo.0803726","article-title":"Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease","volume":"32","author":"Cheng","year":"2008","journal-title":"Int. J. Obes."},{"issue":"19","key":"10.1016\/j.abb.2020.108679_bib173","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.jacc.2015.03.520","article-title":"Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar","volume":"65","author":"Ruiz-Villalba","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib174","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000253","article-title":"The origin of human mesenchymal stromal cells dictates their reparative properties","volume":"2","author":"Naftali-Shani","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib175","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/oby.22608","article-title":"Cardioprotective heme oxygenase-1-PGC-1\u03b1 signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice","volume":"27","author":"Singh","year":"2019","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib176","doi-asserted-by":"crossref","first-page":"H368","DOI":"10.1152\/ajpheart.00093.2017","article-title":"EET intervention on Wnt1, NOV and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice","volume":"313","author":"Cao","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"20","key":"10.1016\/j.abb.2020.108679_bib177","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.ATV.0000251993.20372.40","article-title":"Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study","volume":"27","author":"Lee","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib179","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.ATV.0000253905.13219.4b","article-title":"Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk","volume":"27","author":"Grundy","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"14","key":"10.1016\/j.abb.2020.108679_bib180","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.105.552547","article-title":"Promotion Program Study, G.Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults","volume":"112","author":"Ruttmann","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib181","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1751-7141.2009.00054.x","article-title":"Gamma-glutamyl transferase: a novel cardiovascular risk biomarker","volume":"13","author":"Mason","year":"2010","journal-title":"Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib182","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijcard.2005.06.056","article-title":"Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome","volume":"108","author":"Onat","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.abb.2020.108679_bib183","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cca.2017.11.026","article-title":"Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease","volume":"476","author":"Ndrepepa","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.abb.2020.108679_bib184","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0972-124X.149032","article-title":"Is gamma-glutamyl transpeptidase a biomarker for oxidative stress in periodontitis?","volume":"19","author":"Sreeram","year":"2015","journal-title":"J. Indian Soc. Periodontol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib185","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1038\/s41598-018-29928-z","article-title":"Testing the influence of testosterone administration on men's honesty in a large laboratory experiment","volume":"8","author":"Henderson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2020.108679_bib186","doi-asserted-by":"crossref","first-page":"818570","DOI":"10.1155\/2015\/818570","article-title":"Gamma-Glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib187","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0003319711433197","article-title":"Serum gamma- glutamyltransferase levels correlate with epicardial adipose tissue thickness in patients with coronary artery disease","volume":"64","author":"Ege","year":"2013","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib188","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MOL.0b013e3282ffaf6a","article-title":"N-3 polyunsaturated fatty acid regulation of hepatic gene transcription","volume":"19","author":"Jump","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"issue":"24","key":"10.1016\/j.abb.2020.108679_bib189","article-title":"Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: a protocol for a systematic review and meta-analysis","volume":"99","author":"Shi","year":"2020","journal-title":"Medicine (Baltim.)"},{"issue":"8","key":"10.1016\/j.abb.2020.108679_bib190","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study","volume":"23","author":"Capanni","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib191","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/biof.1246","article-title":"Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis","volume":"41","author":"Huang","year":"2015","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib192","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-017-0431-8","article-title":"Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.abb.2020.108679_bib193","doi-asserted-by":"crossref","first-page":"26826","DOI":"10.1038\/srep26826","article-title":"Dietary alpha-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"sup1","key":"10.1016\/j.abb.2020.108679_bib194","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1080\/10408398.2018.1544542","article-title":"n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review","volume":"59","author":"Wang","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib195","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib196","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib197","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1440-1746.2008.05694.x","article-title":"Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors","volume":"24","author":"St George","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib198","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1381\/096089206778663805","article-title":"Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement","volume":"16","author":"Dixon","year":"2006","journal-title":"Obes. Surg."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib199","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.surg.2003.07.008","article-title":"Socioeconomic characteristics of the population eligible for obesity surgery","volume":"135","author":"Livingston","year":"2004","journal-title":"Surgery"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2020.108679_bib201","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1467-789X.2004.00133.x","article-title":"Obesity in children and young people: a crisis in public health","volume":"5","author":"Lobstein","year":"2004","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib204","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.abb.2020.108679_bib206","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib207","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jhep.2011.03.016","article-title":"The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis","volume":"55","author":"Mahady","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib209","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3748\/wjg.v21.i1.301","article-title":"Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease","volume":"21","author":"Maciejewska","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.abb.2020.108679_bib210","first-page":"485","article-title":"Icosapent ethyl for the treatment of severe hypertriglyceridemia","volume":"10","author":"Fares","year":"2014","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib211","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40256-014-0099-7","article-title":"Icosapent ethyl: a review of its use in severe hypertriglyceridemia","volume":"14","author":"Kim","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"1 Suppl","key":"10.1016\/j.abb.2020.108679_bib212","article-title":"Polyunsaturated fatty acids in the food chain in the United States","volume":"71","author":"Kris-Etherton","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib213","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11745-003-1074-0","article-title":"Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids","volume":"38","author":"Meyer","year":"2003","journal-title":"Lipids"},{"issue":"3 Suppl","key":"10.1016\/j.abb.2020.108679_bib214","doi-asserted-by":"crossref","first-page":"560S","DOI":"10.1093\/ajcn\/70.3.560s","article-title":"Essential fatty acids in health and chronic disease","volume":"70","author":"Simopoulos","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl 1","key":"10.1016\/j.abb.2020.108679_bib215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2165\/00003495-198700331-00003","article-title":"An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes","volume":"33","author":"Samuelsson","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.abb.2020.108679_bib216","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib217","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1039\/c1fo10133a","article-title":"The importance of the long-chain polyunsaturated fatty acid n-6\/n-3 ratio in development of non-alcoholic fatty liver associated with obesity","volume":"2","author":"Valenzuela","year":"2011","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.abb.2020.108679_bib218","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3181\/0711-MR-311","article-title":"The importance of the omega-6\/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases","volume":"233","author":"Simopoulos","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.abb.2020.108679_bib219","doi-asserted-by":"crossref","first-page":"G865","DOI":"10.1152\/ajpgi.2001.281.4.G865","article-title":"Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription","volume":"281","author":"Clarke","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"11","key":"10.1016\/j.abb.2020.108679_bib220","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3945\/jn.110.125732","article-title":"Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation","volume":"140","author":"Kalupahana","year":"2010","journal-title":"J. Nutr."},{"issue":"10","key":"10.1016\/j.abb.2020.108679_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046400","article-title":"N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis","volume":"7","author":"Valenzuela","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.abb.2020.108679_bib222","doi-asserted-by":"crossref","first-page":"5109503","DOI":"10.1155\/2018\/5109503","article-title":"Attenuation of high-fat diet-induced rat liver oxidative stress and steatosis by combined hydroxytyrosol- (HT-) eicosapentaenoic acid supplementation mainly relies on HT","volume":"2018","author":"Echeverria","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"issue":"46","key":"10.1016\/j.abb.2020.108679_bib223","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.1021\/ja064399o","article-title":"In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution","volume":"128","author":"Davis","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2020.108679_bib224","doi-asserted-by":"crossref","first-page":"108330","DOI":"10.1016\/j.jnutbio.2019.108330","article-title":"High ratio of omega-3\/omega-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice","volume":"79","author":"Liu","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"14","key":"10.1016\/j.abb.2020.108679_bib225","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/bph.13844","article-title":"Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease","volume":"174","author":"Wang","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.abb.2020.108679_bib226","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11745-014-3892-9","article-title":"Effects of a diet rich in n-3 polyunsaturated fatty acids on hepatic lipogenesis and beta-oxidation in mice","volume":"49","author":"Bargut","year":"2014","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.abb.2020.108679_bib227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12944-017-0461-2","article-title":"Protective effects of various ratios of DHA\/EPA supplementation on high-fat diet-induced liver damage in mice","volume":"16","author":"Shang","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.abb.2020.108679_bib228","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-\/-) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"Depner","year":"2013","journal-title":"J. Nutr."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:17:11Z","timestamp":1757744231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986120306883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":228,"alternative-id":["S0003986120306883"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2020.108679","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2020.108679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108679"}}